lancet-header

Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.

Gestational Progesterone Restores Menstrual Cycle in PCOS Patients via Enhancing Ovary Estrogen Production

24 Pages Posted: 2 Dec 2024

See all articles by Qiwen Yang

Qiwen Yang

Nanjing Medical University - State Key Laboratory of Reproductive Medicine

Na Kong

Nanjing University - Center for Reproductive Medicine

Jing Wu

Nanjing University - Center for Reproductive Medicine

Yan Yang

Nanjing Medical University - State Key Laboratory of Reproductive Medicine

Han Sha

Nanjing Medical University - State Key Laboratory of Reproductive Medicine

Xinge Zhang

Nanjing Medical University - State Key Laboratory of Reproductive Medicine

Yuan Lin

Nanjing Medical University

Zhibin Hu

Nanjing Medical University - State Key Laboratory of Reproductive Medicine

Guijun Yan

Nanjing University - Center for Reproductive Medicine

Haixiang Sun

Nanjing University - Center for Reproductive Medicine; Nanjing Medical University - State Key Laboratory of Reproductive Medicine; Nanjing University - Center for Reproductive Medicine; Nanjing University - State Key Laboratory of Pharmaceutical Biotechnology

Chaojun Li

Nanjing Medical University - State Key Laboratory of Reproductive Medicine

More...

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, typically characterized by irregular menstrual cycles. Our study found that postpartum menstrual cycles were largely restored in PCOS patients following assisted reproductive technology (ART) therapy. However, this recovery in menstrual cycles was not associated with any specific ART procedures. Using a PCOS mouse model, we demonstrated that elevated progesterone levels during pregnancy are responsible for normalizing estrous cyclicity. Elevated levels of progesterone induce granulosa cell apoptosis and deplete large follicles, which potentially contribute to ovarian function suppression during pregnancy. Mechanistic studies indicated that progesterone decreases FSH receptor (FSHR) expression in a Gata2-dependent manner. Interestingly, the capacity of granulosa cells to convert androgens into estrogens significantly increased after progesterone withdrawal, as evidenced by elevated Cyp19a1 expression in granulosa cells when stimulated with FSH. Additionally, we found that progesterone administration reduced the thickness of the uterine endometrium in PCOS mice. Our findings suggest that sustained high levels of progesterone during pregnancy can enhance ovarian reproductive endocrine capacity and improve endometrial function, thereby facilitating the recovery of postpartum menstrual cycles.


Funding: This work was supported by the National Natural Science Foundation of China (Grant No. 82330050).

Declaration of Interest: No conflicts of interest, financial or otherwise, are declared by the authors.

Ethical Approval: All study participants or their legal authorized representative gave written informed consent for study enrollment in accordance with the Ethics Committee of Nanjing Drum Tower Hospital (No. 2021-433- 01).

Keywords: polycystic ovary syndrome, menstrual cycle, progesterone, granulosa apoptosis

Suggested Citation

Yang, Qiwen and Kong, Na and Wu, Jing and Yang, Yan and Sha, Han and Zhang, Xinge and Lin, Yuan and Hu, Zhibin and Yan, Guijun and Sun, Haixiang and Sun, Haixiang and Li, Chaojun, Gestational Progesterone Restores Menstrual Cycle in PCOS Patients via Enhancing Ovary Estrogen Production. Available at SSRN: https://ssrn.com/abstract=5035919 or http://dx.doi.org/10.2139/ssrn.5035919

Qiwen Yang

Nanjing Medical University - State Key Laboratory of Reproductive Medicine ( email )

Na Kong

Nanjing University - Center for Reproductive Medicine ( email )

Jing Wu

Nanjing University - Center for Reproductive Medicine ( email )

Yan Yang

Nanjing Medical University - State Key Laboratory of Reproductive Medicine ( email )

Han Sha

Nanjing Medical University - State Key Laboratory of Reproductive Medicine ( email )

Xinge Zhang

Nanjing Medical University - State Key Laboratory of Reproductive Medicine ( email )

Yuan Lin

Nanjing Medical University ( email )

300 Guangzhou Road
Nanjing, 210029
China

Zhibin Hu

Nanjing Medical University - State Key Laboratory of Reproductive Medicine ( email )

Guijun Yan

Nanjing University - Center for Reproductive Medicine ( email )

Haixiang Sun

Nanjing University - Center for Reproductive Medicine ( email )

China

Nanjing Medical University - State Key Laboratory of Reproductive Medicine ( email )

Nanjing University - Center for Reproductive Medicine ( email )

China

Nanjing University - State Key Laboratory of Pharmaceutical Biotechnology ( email )

Nanjing
China

Chaojun Li (Contact Author)

Nanjing Medical University - State Key Laboratory of Reproductive Medicine ( email )